Ad is loading...
ADNRX vs FSMAX
ADNRX vs FSMAX Comparison
Open Charts ADNRX vs FSMAX
American Beacon ARK Transfmt Innov R6
Price$15.86
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Fidelity Extended Market Index
Price$96.46
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
ADNRX vs FSMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
ADNRX vs. FSMAX commentary
Nov 12, 2024
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Hold and FSMAX is a Buy.
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40B vs. ADNRX (204M). FSMAX pays higher dividends than ADNRX: FSMAX (1.10) vs ADNRX (0.00). ADNRX was incepted earlier than FSMAX: ADNRX (4 years) vs FSMAX (13 years). ADNRX is a more actively managed with annual turnover of: 33.00 vs. FSMAX (18.00). ADNRX (0) and FSMAX (0) have matching initial minimum investment requirements. FSMAX (46.02) and ADNRX (45.64) have marching annual gain over last year.
| ADNRX | FSMAX | ADNRX / FSMAX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 4 years | 13 years | - |
| Gain YTD | 10.446 | 23.572 | 44% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 204M | 40B | 1% |
| Annual Yield % from dividends | 0.00 | 1.10 | - |
| Returns for 1 year | 45.64 | 46.02 | 99% |
| Returns for 3 years | -63.98 | 4.54 | -1,409% |
| Returns for 5 years | N/A | 58.87 | - |
| Returns for 10 years | N/A | 89.62 | - |
View a ticker or compare two or three
VS
VS
Ad is loading...